Showing results (71-80 of 252) with videos related to
Sort By:
Pageof 26
Plos One|April 23, 2016
Reasons for Journal Impact Factor Changes: Influence of Changing Source ItemsTobias Kiesslich, Silke B Weineck, Dorothea KoelblingerPhotochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|March 28, 2003
Characterization of the cell death modes and the associated changes in cellular energy supply in response to AlPcS4-PDTKristjan Plaetzer, Tobias Kiesslich, Barbara Krammer, et al.Biomed Research International|March 20, 2013
Photosensitizer adhered to cell culture microplates induces phototoxicity in carcinoma cellsVerena Ziegler, Tobias Kiesslich, Barbara Krammer, et al.Hepatology (Baltimore, Md.)|May 21, 2015
Temoporfin improves efficacy of photodynamic therapy in advanced biliary tract carcinoma: A multicenter prospective phase II studyAndrej Wagner, Ulrike W Denzer, Daniel Neureiter, et al.Photochemistry and Photobiology|January 4, 2003
Glucose is required to maintain high ATP-levels for the energy-utilizing steps during PDT-induced apoptosisChristian Benno Oberdanner, Tobias Kiesslich, Barbara Krammer, et al.Plos One|November 23, 2019
Size matters! Association between journal size and longitudinal variability of the Journal Impact FactorDorothea Koelblinger, Georg Zimmermann, Silke B Weineck, et al.International Journal of Molecular Medicine|February 9, 2006
Gastrointestinal cancer - only a deregulation of stem cell differentiation? (Review)Daniel Neureiter, Christoph Herold, Matthias OckerExpert Review of Anticancer Therapy|November 25, 2025
Targeted therapy for biliary tract cancer: facts and fictions as well as demands and challengesDaniel Neureiter, Peter Ellinghaus, Matthias OckerCurrent Pharmaceutical Design|April 28, 2005
Apoptosis following photodynamic tumor therapy: induction, mechanisms and detectionKristjan Plaetzer, Tobias Kiesslich, Christian Benno Oberdanner, et al.Histology and Histopathology|February 19, 2009
Biomarkers for novel targeted therapies of hepatocellular carcinomaKinya Okamoto, Daniel Neureiter, Matthias OckerPageof 26